Garwan Yusuf M, Alsalloum Muath A, Thabit Abrar K, Jose Jimmy, Eljaaly Khalid
Department of Pharmacy Practice, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Department of Pharmacy Practice, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Am J Infect Control. 2023 Jan;51(1):89-98. doi: 10.1016/j.ajic.2022.05.017. Epub 2022 May 27.
This review aimed to summarize the available evidence on the effectiveness and safety of antimicrobial stewardship interventions to improve the practice of IV-to-PO antimicrobial switch therapy in hospitalized adults.
Following the PRISMA guidelines, we searched Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE/PubMed, and Scopus from inception to September 1, 2020, for original articles investigating any interventions aimed to improve the practice of IV-to-PO antimicrobial switch therapy in hospitalized adults with infectious diseases. We included randomized controlled trials (RCTs) and quasi-experimental studies. Studies were excluded if they evaluated drugs other than antimicrobials, head-to-head comparison of interventions, included pediatrics or oncology patients.
Of 506 unique citations identified, 36 studies met the inclusion criteria. The 36 included studies reported 92 interventions as a single (n = 10) or a bundle of interventions (n = 26). The most common interventions used were guideline/protocol/pathway (n = 25), audit and feedback (n = 20), and education (n = 17).
This review provides health care providers with a comprehensive summary on the interventions to promote IV-to-PO antimicrobial switch. While no one intervention could be identified as the safest and most effective as most of the included studies used a bundle of interventions, all interventions resulted in optimizing antibiotic use and reducing health care expenditures without compromising the clinical outcomes. As such, each hospital should design and utilize interventions that are applicable based on available resources and expertise.
本综述旨在总结抗菌药物管理干预措施在改善住院成人患者静脉给药至口服给药抗菌药物转换治疗实践方面的有效性和安全性的现有证据。
遵循PRISMA指南,我们检索了Cochrane对照试验中心注册库(CENTRAL)、MEDLINE/PubMed以及Scopus数据库,检索时间从建库至2020年9月1日,以查找调查旨在改善住院感染性疾病成人患者静脉给药至口服给药抗菌药物转换治疗实践的任何干预措施的原始文章。我们纳入了随机对照试验(RCT)和准实验研究。如果研究评估的不是抗菌药物、干预措施的直接比较、纳入了儿科或肿瘤患者,则将其排除。
在识别出的506篇独特文献中,36项研究符合纳入标准。这36项纳入研究报告了92项干预措施,其中单项干预措施(n = 10)或一系列干预措施(n = 26)。最常用的干预措施是指南/协议/路径(n = 25)、审核与反馈(n = 20)以及教育(n = 17)。
本综述为医疗保健提供者提供了关于促进静脉给药至口服给药抗菌药物转换的干预措施的全面总结。虽然由于大多数纳入研究使用了一系列干预措施,无法确定哪一项干预措施是最安全、最有效的,但所有干预措施都优化了抗生素使用并降低了医疗保健支出,同时不影响临床结局。因此,每家医院应根据可用资源和专业知识设计并采用适用的干预措施。